ATB-1651
N/A
Report date: 2025/03/10 14:56:26
NMEFirst In Class
Base Information
Drug NameATB-1651
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmtixBio Corp
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A